APA (7th ed.) Citation

D, M., M, D., AJ, E., B, W., T, G., A, T., & GR, W. (2021). Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD. Journal of medical economics, 24(1), 939. https://doi.org/10.1080/13696998.2021.1960682

Chicago Style (17th ed.) Citation

D, Mehta, Davis M, Epstein AJ, Wensel B, Grinnell T, Thach A, and Williams GR. "Comparative Economic Outcomes in Patients with Focal Seizures Initiating Eslicarbazepine Acetate Versus Brivaracetam as Their First Adjunctive ASD." Journal of Medical Economics 24, no. 1 (2021): 939. https://doi.org/10.1080/13696998.2021.1960682.

MLA (9th ed.) Citation

D, Mehta, et al. "Comparative Economic Outcomes in Patients with Focal Seizures Initiating Eslicarbazepine Acetate Versus Brivaracetam as Their First Adjunctive ASD." Journal of Medical Economics, vol. 24, no. 1, 2021, p. 939, https://doi.org/10.1080/13696998.2021.1960682.